Luo Ying sold GYRE
May 5, 2026 · Form 4 insider transaction
Luo Ying sold 179 shares of Gyre Therapeutics, Inc. at $8.01 per share, a transaction worth $1.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
179
Price
$8.01
Total value
$1.4K
InsiderLuo Ying
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 5, 2026
Filing dateMay 7, 2026
Shares owned after2,575,362
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.